Randomized Trial of Suicide Gene Therapy and Prostate Cancer

Clinical trial NCT00583492 · COMPLETED

Trial details

NCT number: NCT00583492
Sponsor: Henry Ford Health System
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2007-12-01
Primary completion: 2013-09-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.